Welwyn, United Kingdom

Ian F Skidmore


Average Co-Inventor Count = 5.2

ph-index = 13

Forward Citations = 542(Granted Patents)


Location History:

  • Herts, GB (1992 - 1993)
  • Welwyn, GB (1988 - 1994)

Company Filing History:


Years Active: 1988-1994

Loading Chart...
24 patents (USPTO):Explore Patents

Title: Ian F Skidmore: Innovator in Pharmaceutical Patents

Introduction

Ian F Skidmore, based in Welwyn, Great Britain, is a prominent inventor recognized for his substantial contributions to the field of pharmaceuticals. With a remarkable portfolio of 24 patents, Skidmore has dedicated his career to advancing medical science through innovative inventions that address various health challenges.

Latest Patents

Among his latest patents are the Phenethanolamine derivatives, which provide compounds of a specific general formula aimed at yielding physiologically acceptable salts or solvates. These innovative compounds demonstrate stimulant action at beta-2 adrenoreceptors, indicating potential use in treating diseases associated with reversible airway obstruction, such as asthma and chronic bronchitis. This invention showcases Skidmore's commitment to developing solutions for critical respiratory conditions.

Career Highlights

Skidmore's professional journey is marked by his role at Glaxo Group Limited, a significant player in the pharmaceutical industry. His work has not only resulted in multiple patents but also contributed to advancements in therapeutic treatments that have the potential to improve patients' quality of life. His expertise and dedication reflect the innovative spirit of the organization he represents.

Collaborations

Throughout his career, Ian F Skidmore has collaborated with notable colleagues, including Lawrence H Lunts and Harry Finch. These partnerships illustrate the importance of teamwork in fostering innovation and developing groundbreaking pharmaceutical solutions.

Conclusion

In summary, Ian F Skidmore exemplifies the role of an inventor in the ever-evolving field of pharmaceuticals. His contributions through numerous patents, particularly in the area of Phenethanolamine derivatives, highlight his commitment to addressing pressing health issues. As he continues his work at Glaxo Group Limited, Skidmore remains a key figure in the innovation landscape of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…